The Full Wiki

Levocetirizine: Wikis

  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Levocetirizine
Systematic (IUPAC) name
2-[2-[4-[(R)-(4-chlorophenyl)-phenyl-methyl]
piperazin-1-yl]ethoxy]acetic acid
Identifiers
CAS number 130018-77-8
ATC code R06AE09
PubChem 1549000
Chemical data
Formula C21H25ClN2O3 
Mol. mass 388.888 g/mol
Pharmacokinetic data
Bioavailability High
Protein binding 90%
Metabolism Hepatic 14% CYP3A4
Half life 6 to 10 hours
Excretion Renal and fecal
Therapeutic considerations
Pregnancy cat. B(US)
Legal status POM (UK) -only (US)
Routes Oral
Xyzal

Levocetirizine (as levocetirizine dihydrochloride) is a third-generation non-sedative antihistamine, developed from the second-generation antihistamine cetirizine. Chemically, levocetirizine is the active enantiomer of cetirizine. It is the L-enantiomer of the cetirizine racemate. Levocetirizine works by blocking histamine receptors. It does not prevent the actual release of histamine from mast cells, but prevents it binding to its receptors. This in turn prevents the release of other allergy chemicals and increased blood supply to the area, and provides relief from the typical symptoms of hayfever.

It is claimed to be more effective and with fewer side effects than the second-generation drugs; however, this claim is not clearly supported by the available clinical literature.[citation needed]

Contents

History and formulations

Levocetirizine was first launched in 2001 by Belgian pharmaceutical company UCB with the brand name Xyzal (pronounced /ˈzaɪzæl/) in Austria, Finland, France, Ireland, Netherlands, Portugal, Romania, United States, UK; Xuzal in Mexico; Xusal in Germany; and Xozal in Greece. In India, levocetirizine is marketed by GlaxoSmithKline under the brand name Vozet and Xyzal. On May 25, 2007, the United States Food and Drug Administration approved Xyzal, where it is co-marketed by Sanofi-Aventis.Torrent Pharma launched UVNIL in rural market of INDIA. It is also available as LEZYNCET 5 mg tablets through Unichem in India.In India, generic name of Lev-Cit 5mg is manufactured by VIP Pharmaceuticals.

It is available as 5 mg-strength tablets and a 0.5 mg/mL oral solution.

In Pakistan levocetirizine is available in liquid formulation as well with the name of OCITRA 2.5mg/5ml.

In Egypt is available as 5-strength tablets with the name of ALLEAR tab.

Side effects

Levocetirizine is called a non-sedating antihistamine as it does not enter the brain in significant amounts, and is therefore unlikely to cause drowsiness. However, some people may experience some slight sleepiness, headache, mouth dryness, lightheadedness, vision problems (mainly blurred vision), palpitations and fatigue.[1]

Research

Latest research shows levocetirizine reduces asthma attacks by 70% in children.[2]

Availability

The drug is currently available on prescription in the United States. Although the drug was only authorized by the FDA on 25 May 2007, it was already available in most European countries. As for many new drugs it entered the market at a higher price than currently available third- and second-generation antihistamines.
In India, one form of the drug is available as "LevoKast" tablets, marketed by [TTK Healthcare Ltd][1]. The "LevoKast" is a formulation of Levocetirizine Hydrochloride & Montelukast. The "LevoKast" is a Schedule 'H' Drug and can be taken on the prescription by a Registered Medical Practitioner only.

References








Got something to say? Make a comment.
Your name
Your email address
Message